Karen Sue Kehl, PhD

Professor

view physician profile

Locations

Pathology - Children's

Specialties

Pathology
Microbiology

Languages

English

Education

Biography

Dr. Kehl provides medical, scientific and technical direction for the departments of microbiology, virology and molecular infectious disease testing at Children’s Hospital of Wisconsin. She is responsible for the implementation of new assays and provides guidance to providers on test selection and interpretation of test results. Dr. Kehl is also an associate director of clinical pathology at Children’s Hospital. In that role, she provides oversight and direction of the quality management program. Dr. Kehl is the course director for the PGY-2 microbiology rotation. She provides training and oversight of the pathology residents in clinical microbiology. Additionally, she serves as a co-chair of the Children’s Hospital of Wisconsin Institutional Review Board.

Research Interests

Development and evaluation of molecular methods for the detection of agents of infectious disease

Study of Powassan virus epidemiology

Blastomycosis in 64 Wisconsin Children: Unanticipated Infection Risk and Severity in Urban Residents.

(Hall JM, Havens PL, Mitchell EA, De Vela GN, Titus LL, Dasgupta M, Simpson PM, Kehl SC, Willoughby RE, Henrickson KJ, Mitchell ML, Huppler AR, Chusid MJ.) Pediatr Infect Dis J. 2021 Sep 01;40(9):802-807 PMID: 33990518 SCOPUS ID: 2-s2.0-85112752993 05/16/2021
A Novel Multiplexed Enzyme-Linked Immunosorbent Assay for the Detection of IgG Seroreactivity to Cytomegalovirus (CMV) UL144.

(Miller H, Simpson P, Forman M, Prigan A, Kehl S, Mesich B, Faron M, Ledeboer N, Arav-Boger R.) J Clin Microbiol. 2021 07 19;59(8):e0096421 PMID: 34076473 PMCID: PMC8373222 SCOPUS ID: 2-s2.0-85112127278 06/03/2021
COVID-19 pre-procedural testing strategy and early outcomes at a large tertiary care children's hospital.

(Bence CM, Jarzembowski JA, Belter L, Berens RJ, Henrickson KJ, Hoffman GM, Jackson F, Kehl KS, Oldham KT, Scott JP, Tassone JC, Woger N, Yale E, Gourlay DM.) Pediatr Surg Int. 2021 Jul;37(7):871-880 PMID: 33715083 PMCID: PMC7955904 SCOPUS ID: 2-s2.0-85102600575 03/15/2021
Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non-Small Cell Lung Cancer.

(Kehl KL, Greenwald S, Chamoun NG, Manberg PJ, Schrag D.) JAMA Netw Open. 2021 May 03;4(5):e2111113 PMID: 34019086 PMCID: PMC8140374 05/22/2021
Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.

(Kociolek LK, Muller WJ, Yee R, Dien Bard J, Brown CA, Revell PA, Wardell H, Savage TJ, Jung S, Dominguez S, Parikh BA, Jerris RC, Kehl SC, Campigotto A, Bender JM, Zheng X, Muscat E, Linam M, Abuogi L, Smith C, Graff K, Hernandez-Leyva A, Williams D, Pollock NR.) J Clin Microbiol. 2020 12 17;59(1) PMID: 33093026 PMCID: PMC7771452 SCOPUS ID: 2-s2.0-85097028884 10/24/2020
Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia.

(Erker C, Huppler AR, Walsh TJ, McCormick ME, Suchi M, Bhatt NS, Kehl SC, Southwood J, Harker-Murray P.) J Pediatr Hematol Oncol. 2018 10;40(7):e446-e449 PMID: 28991126 PMCID: PMC5904005 SCOPUS ID: 2-s2.0-85031495362 10/11/2017
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

(Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S 3rd, Theel ES, Thomson RB Jr, Weinstein MP, Yao JD.) Clin Infect Dis. 2018 08 31;67(6):813-816 PMID: 30169655 SCOPUS ID: 2-s2.0-85053726304 09/01/2018
Practical Guidance for Clinical Microbiology Laboratories: Implementing a Quality Management System in the Medical Microbiology Laboratory

(Carey RB, Bhattacharyya S, Kehl SC, Matukas LM, Pentella MA, Salfinger M, Schuetz AN.) Clin Microbiol Rev. 2018 07;31(3) PMID: 29720490 PMCID: PMC6056841 SCOPUS ID: 2-s2.0-85047941100 05/04/2018
Development and Validation of a Serologic Test Panel for Detection of Powassan Virus Infection in U.S. Patients Residing in Regions Where Lyme Disease Is Endemic.

(Thomm AM, Schotthoefer AM, Dupuis AP 2nd, Kramer LD, Frost HM, Fritsche TR, Harrington YA, Knox KK, Kehl SC.) mSphere. 2018 Jan-Feb;3(1) PMID: 29359181 PMCID: PMC5760746 SCOPUS ID: 2-s2.0-85041524474 01/24/2018
Serologic Evidence of Powassan Virus Infection in Patients with Suspected Lyme Disease1.

(Frost HM, Schotthoefer AM, Thomm AM, Dupuis AP 2nd, Kehl SC, Kramer LD, Fritsche TR, Harrington YA, Knox KK.) Emerg Infect Dis. 2017 08;23(8):1384-1388 PMID: 28726610 PMCID: PMC5547799 SCOPUS ID: 2-s2.0-85025075990 07/21/2017
Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial.

(Kehl SC, Dowzicky MJ.) J Clin Microbiol. 2015 Apr;53(4):1286-93 PMID: 25653413 PMCID: PMC4365249 SCOPUS ID: 2-s2.0-84925267677 02/06/2015